Congo, Democratic Republic of the vs Oman: Protecting minority investors: Ease of shareholder suits index (0-10)
Congo, Democratic Republic of the
30
in 2019
Oman
30
in 2019
Congo, Democratic Republic of the rank
175th
Oman rank
175th
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Congo, Democratic Republic of the
- Oman
How they compare
Congo, Democratic Republic of the currently reports 30 against 30 in Oman, a difference of 0.
Across all 7 years both countries report, Oman has been ahead every year.
Congo, Democratic Republic of the ranks 175th and Oman ranks 175th of 191 countries.
Oman has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Congo, Democratic Republic of the or Oman?
- Congo, Democratic Republic of the, at 30 against 30 in Oman as of 2019.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Congo, Democratic Republic of the and Oman?
- 0, with Congo, Democratic Republic of the ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Oman?
- 7 years are reported by both, from 2013 to 2019.
- How do Congo, Democratic Republic of the and Oman rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Congo, Democratic Republic of the ranks 175th and Oman ranks 175th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB15-20 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB15-20 studies.